GO:0006289 nucleotide-excision repair: DNA Damage Repair Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006289 nucleotide-excision repair (NER) is a versatile DNA repair process that removes a short oligonucleotide containing UV-induced pyrimidine dimers, 6-4 photoproducts, intrastrand cross-links, and bulky chemical adducts.
• NER operates through two main subpathways: global genome NER (GG-NER) and transcription-coupled NER (TC-NER), which differ in damage recognition but share the core excision and resynthesis machinery.
• Core NER proteins include XPA, XPC, XPD (ERCC2), XPB (ERCC3), XPF (ERCC4), XPG (ERCC5), CSA (ERCC8), CSB (ERCC6), and the UV-DDB complex, many of which are mutated in xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.
• Defective NER causes cancer predisposition, neurodegeneration, and developmental abnormalities, making NER genes important targets for disease modeling and therapeutic research.
• CRISPR knockout, point-mutation knock-in, and overexpression cell models enable causal interrogation of NER gene function and variant pathogenicity.
• NER is epigenetically regulated and functionally coupled to transcription, replication, and chromatin remodeling, influencing genome stability and cellular stress responses.
Description
Nucleotide-excision repair (NER) is a highly conserved DNA repair pathway that removes a wide spectrum of helix-distorting lesions from DNA, including ultraviolet (UV)-induced cyclobutane pyrimidine dimers and 6-4 photoproducts, as well as intrastrand cross-links and bulky chemical adducts. Unlike base excision repair, which handles small non-helix-distorting lesions, NER excises a short single-stranded oligonucleotide containing the damage and then fills the resulting gap by DNA synthesis and ligation. This mechanism is essential for maintaining genome integrity in organisms exposed to environmental genotoxins and endogenous DNA-damaging agents. Research into NER has revealed two major subpathways: global genome NER (GG-NER), which surveys the entire genome for damage, and transcription-coupled NER (TC-NER), which specifically repairs lesions that block RNA polymerase II elongation. These subpathways converge on a common core excision machinery, but their damage recognition and initiation steps are distinct. The biological importance of NER is underscored by inherited human disorders such as xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy, which arise from mutations in NER genes and present with photosensitivity, cancer predisposition, neurological abnormalities, and developmental defects. For researchers, GO:0006289 represents a central node linking DNA damage sensing, chromatin dynamics, transcription, and cell fate decisions. Understanding NER at molecular, cellular, and organismal levels requires integrated approaches, including CRISPR-based gene editing, functional genomics, and high-throughput screening. This article provides a research-grade overview of the NER pathway, its key genes, disease relevance, and experimental strategies for studying it.
nucleotide-excision repair At A Glance
| GO ID | GO:0006289 |
|---|---|
| GO term | nucleotide-excision repair |
| Ontology | biological_process |
| Synonym | intrastrand cross-link repair; NER; pyrimidine-dimer repair; DNA damage excision |
| Definition | A DNA repair process in which a small region of the strand surrounding the damage is removed from the DNA helix as an oligonucleotide; the gap is filled by DNA polymerase and DNA ligase. |
| Major function | Recognition and removal of helix-distorting DNA lesions, including UV photoproducts and bulky adducts, to maintain genome integrity. |
| Subpathways | Global genome NER (GG-NER) and transcription-coupled NER (TC-NER). |
| Key diseases | Xeroderma pigmentosum, Cockayne syndrome, trichothiodystrophy, and cancer predisposition. |
| Core genes | XPA, XPC, XPD/ERCC2, XPB/ERCC3, XPF/ERCC4, XPG/ERCC5, CSA/ERCC8, CSB/ERCC6, DDB1, DDB2, CUL4A. |
What Is GO:0006289?
GO:0006289 nucleotide-excision repair is a biological process in which a small region of the DNA strand surrounding a lesion is removed as an oligonucleotide, leaving a gap that is filled by DNA polymerase and sealed by DNA ligase. This repair mechanism recognizes a broad range of substrates, including UV-induced pyrimidine dimers and 6-4 photoproducts, intrastrand cross-links, and bulky chemical adducts. The term is synonymous with intrastrand cross-link repair, NER, pyrimidine-dimer repair, and DNA damage excision.
Why Is nucleotide-excision repair Important in Cell Biology?
NER is essential for protecting cells from the mutagenic and cytotoxic effects of UV radiation and chemical carcinogens, and its dysfunction leads to severe human diseases characterized by photosensitivity, neurodegeneration, developmental defects, and cancer predisposition. Beyond its canonical role in DNA repair, NER is integrated with transcription, chromatin remodeling, and cell cycle regulation, influencing genome stability and cellular stress responses. Understanding NER mechanisms provides insights into cancer biology, aging, and neurodevelopment, and supports the development of targeted therapies and diagnostic tools.
• Prevents mutations and cell death caused by UV-induced pyrimidine dimers and 6-4 photoproducts.
• Protects against bulky chemical adducts and intrastrand cross-links from environmental carcinogens.
• Defects in NER cause xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.
• NER gene mutations are associated with increased cancer risk, especially skin cancer.
• TC-NER is critical for resolving transcription-blocking lesions and preventing transcription-associated genome instability.
• NER is developmentally important, as shown by embryonic lethality in NER-deficient animal models.
• Epigenetic regulation of NER influences repair efficiency and cellular sensitivity to DNA-damaging agents.
• NER proteins interact with cell cycle checkpoints, apoptosis, and senescence pathways.
• NER activity modulates responses to platinum-based chemotherapies and other DNA-damaging drugs.
• NER research informs biomarker development and personalized cancer therapy strategies.
What Happens During nucleotide-excision repair?
Damage recognition in global genome NER (GG-NER)
In simple terms: The cell scans the entire genome for DNA damage using specialized sensor proteins.
In GG-NER, the XPC-RAD23B complex and the UV-DDB (DDB1-DDB2) complex recognize helix-distorting lesions such as UV photoproducts. XPC binds to the undamaged strand opposite the lesion and initiates recruitment of the transcription factor IIH (TFIIH) complex. The UV-DDB complex enhances recognition of cyclobutane pyrimidine dimers, which are less efficiently detected by XPC alone.
Damage recognition in transcription-coupled NER (TC-NER)
In simple terms: When RNA polymerase gets stuck at a DNA lesion, it calls in repair proteins to fix the damage.
TC-NER is initiated when RNA polymerase II stalls at a transcription-blocking lesion. The CSA (ERCC8) and CSB (ERCC6) proteins, along with additional factors, recognize the stalled elongation complex and recruit the core NER machinery. This subpathway ensures rapid repair of the transcribed strand, maintaining gene expression and preventing transcription-associated genome instability.
Core excision and dual incision
In simple terms: The damaged piece of DNA is cut out like a patch from a torn fabric.
Following damage recognition, TFIIH unwinds DNA around the lesion using its XPB and XPD helicase subunits, creating a repair bubble. XPA and RPA stabilize the open complex, while XPG and XPF-ERCC1 endonucleases make incisions 3' and 5' to the damage, respectively. This dual incision releases a 24-32 nucleotide oligonucleotide containing the lesion.
DNA synthesis and ligation
In simple terms: The gap left after cutting out the damage is filled in and sealed.
The gap generated by dual incision is filled by DNA polymerase delta, epsilon, or kappa, depending on the context, using the undamaged strand as a template. PCNA and RFC coordinate polymerase loading and processivity. Finally, DNA ligase I or III seals the nick, restoring the DNA duplex.
Chromatin remodeling and repair completion
In simple terms: The DNA is packaged around proteins, so the repair machinery must also rearrange these proteins to access damage.
NER occurs in the context of chromatin, and access to lesions requires nucleosome remodeling and histone modifications. Chromatin remodelers and histone chaperones facilitate repair factor recruitment and restore chromatin structure after repair. Epigenetic marks, including histone acetylation and methylation, influence NER efficiency and subpathway choice.
Key Genes Involved in GO:0006289 nucleotide-excision repair
The following genes encode core and accessory proteins that mediate nucleotide-excision repair, including damage recognition, excision, and resynthesis factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XPA | Damage verification and stabilization of the open complex | Mutations cause xeroderma pigmentosum; key target for functional studies |
| XPC | Primary damage sensor in GG-NER | Mutations cause XP; biomarker for UV sensitivity |
| ERCC2 (XPD) | TFIIH helicase subunit; DNA unwinding | Mutations cause XP, TTD, and CS; target for structural studies |
| ERCC3 (XPB) | TFIIH helicase subunit; DNA unwinding | Mutations cause XP and TTD; essential for transcription and repair |
| ERCC4 (XPF) | 5' incision endonuclease | Mutations cause XP and progeroid syndromes; target for cancer research |
| ERCC5 (XPG) | 3' incision endonuclease | Mutations cause XP and CS; involved in transcription-coupled repair |
| ERCC8 (CSA) | TC-NER initiation factor | Mutations cause Cockayne syndrome; model for neurodegeneration |
| ERCC6 (CSB) | TC-NER initiation factor; chromatin remodeling | Mutations cause CS; links transcription and repair |
| DDB1 | UV-DDB complex subunit; damage recognition | Mutations linked to XP; target for protein interaction studies |
| DDB2 | UV-DDB complex subunit; damage recognition | Mutations cause XP; regulates GG-NER |
| CUL4A | E3 ubiquitin ligase; regulates DDB2 and XPC | Modulates NER efficiency; target for epigenetic studies |
| RAD23B | XPC partner; stabilizes damage recognition complex | Supports GG-NER; target for structural biology |
| RPA1 | Single-stranded DNA binding; stabilizes repair intermediates | Essential for NER; target for functional assays |
| PCNA | Polymerase processivity factor; coordinates resynthesis | Required for repair synthesis; target for cell cycle studies |
| RFC1 | Clamp loader for PCNA | Facilitates polymerase loading; target for biochemical assays |
| LIG1 | DNA ligase I; seals repair patch | Final step of NER; target for enzymatic studies |
| CETN2 | Centrin-2; interacts with XPC and regulates NER | Modulates GG-NER; emerging research target |
How Is nucleotide-excision repair Regulated?
NER is regulated at multiple levels, including transcription, post-translational modifications, and chromatin context. Transcription factors and epigenetic modifiers control the expression of NER genes, while ubiquitination and phosphorylation regulate the stability and activity of repair proteins such as XPC and DDB2. TC-NER is tightly coupled to RNA polymerase II elongation and is influenced by transcription-associated factors. Additionally, cell cycle checkpoints and DNA damage response kinases, including ATM and ATR, modulate NER efficiency and coordination with other repair pathways.
nucleotide-excision repair and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XPA | Xeroderma pigmentosum; UV sensitivity | CRISPR knockout in keratinocytes or fibroblasts |
| XPC | Xeroderma pigmentosum; cancer predisposition | Point-mutation knock-in to model patient variants |
| ERCC8 (CSA) | Cockayne syndrome; neurodegeneration | Knockout in neuronal cells or organoids |
| ERCC6 (CSB) | Cockayne syndrome; transcription stress | Tagged knock-in for live-cell imaging |
| ERCC2 (XPD) | Trichothiodystrophy; XP | Overexpression and point-mutation models |
Xeroderma pigmentosum and cancer predisposition
Biallelic mutations in NER genes such as XPA, XPC, ERCC2, ERCC3, ERCC4, and ERCC5 cause xeroderma pigmentosum, characterized by extreme photosensitivity, freckling, and a markedly increased risk of skin cancers. Cells from XP patients are defective in removing UV-induced DNA lesions, leading to mutations and genomic instability. Research using XP patient-derived cells and CRISPR models has elucidated genotype-phenotype relationships and identified potential therapeutic targets.
Cockayne syndrome and neurodegeneration
Mutations in ERCC8 (CSA) and ERCC6 (CSB) cause Cockayne syndrome, a disorder featuring growth failure, neurological degeneration, and premature aging without cancer predisposition. TC-NER deficiency leads to accumulation of transcription-blocking lesions, triggering cellular stress and apoptosis in post-mitotic cells. Studies in CS models have linked defective TC-NER to mitochondrial dysfunction and neuroinflammation.
Trichothiodystrophy and developmental abnormalities
Mutations in ERCC2 and ERCC3 can cause trichothiodystrophy, characterized by brittle hair, ichthyosis, and developmental delay. These mutations often impair both NER and transcription, highlighting the dual role of TFIIH subunits. Animal models with NER gene knockouts have revealed essential roles in embryonic development and organogenesis.
NER in cancer therapy and drug resistance
NER activity influences sensitivity to platinum-based chemotherapies and other DNA-damaging agents. High NER capacity in tumor cells can confer resistance to cisplatin, making NER components potential biomarkers and therapeutic targets. Conversely, NER deficiency may sensitize tumors to specific drugs, supporting personalized treatment strategies.
From nucleotide-excision repair-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of XPA impair UV-induced DNA repair? | CRISPR knockout cell line (e.g., HeLa, HEK293T) |
| How does a patient-derived XPC mutation affect NER activity? | Point-mutation knock-in via CRISPR |
| Where does CSB localize after UV damage? | Tagged knock-in (e.g., GFP-CSB) |
| Does overexpression of XPC enhance repair capacity? | Overexpression cell model |
| Which genes modulate NER efficiency genome-wide? | CRISPR library screening |
| How does NER deficiency affect transcription? | RNA-seq in knockout models |
How to Study the nucleotide-excision repair Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and UV sensitivity | Identify novel NER modifiers |
| RNA-seq | Transcriptional changes after DNA damage | Analyze TC-NER defects |
| Proteomics (AP-MS) | Protein-protein interactions | Map NER complex composition |
| Live-cell imaging | Repair protein recruitment kinetics | Study real-time NER dynamics |
| Comet assay | DNA strand breaks and repair | Quantify NER capacity |
| Immunofluorescence | Repair foci formation | Assess XPC, XPA recruitment |
| CRISPR knock-in | Tagged protein expression | Track endogenous NER proteins |
| Bioinformatics pathway analysis | Gene set enrichment | Interpret NER-related omics data |
CRISPR-based functional genomics
CRISPR knockout and knock-in screens enable systematic interrogation of NER gene function and variant effects. Pooled sgRNA libraries targeting NER genes can identify modifiers of UV sensitivity or drug response. These approaches are complemented by bioinformatics analysis to prioritize candidate genes and pathways.
Transcriptomics and RNA-seq
RNA-seq measures global gene expression changes following DNA damage or NER gene perturbation. It reveals transcription-coupled repair defects and downstream stress responses. Comparative transcriptomics in NER-deficient and proficient cells identifies pathway crosstalk and biomarkers.
Proteomics and protein interaction studies
Affinity purification and mass spectrometry map NER protein complexes and post-translational modifications. Proximity labeling and yeast two-hybrid assays identify novel interactors. These methods reveal dynamic assembly of repair complexes at damage sites.
Imaging and single-cell assays
Live-cell imaging with fluorescently tagged NER proteins tracks recruitment kinetics to UV-induced lesions. Single-cell DNA damage assays, such as comet assay and immunofluorescence for repair markers, quantify repair efficiency. These techniques are valuable for studying heterogeneity in repair capacity.
How CRISPR Can Be Used to Study GO:0006289 nucleotide-excision repair
Knockout
CRISPR knockout of NER genes such as XPA, XPC, or ERCC8 creates isogenic models to study loss-of-function phenotypes, including UV sensitivity, repair kinetics, and transcriptional stress. These models are valuable for validating gene-disease associations and testing therapeutic interventions.
Point Mutation
Point-mutation knock-in via CRISPR allows modeling of patient-specific missense or nonsense variants in NER genes, enabling genotype-phenotype studies and drug response assays. This approach is particularly useful for variants of uncertain significance in XP and CS genes.
Knock-in
Tagged knock-in of NER genes with fluorescent or affinity tags enables live-cell imaging, protein interaction studies, and chromatin immunoprecipitation. Knock-in of reporter cassettes can also monitor repair activity in real time.
Overexpression
Overexpression of NER genes, such as XPC or XPA, can enhance repair capacity and protect cells from DNA damage. Overexpression models are used to study gain-of-function effects, protein stoichiometry, and resistance to DNA-damaging agents.
How EDITGENE Supports nucleotide-excision repair Research
Researchers studying nucleotide-excision repair-related genes often need to determine whether a candidate gene is causally involved in DNA repair, disease susceptibility, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for NER research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for nucleotide-excision repair research.
Frequently Asked Questions About nucleotide-excision repair
What is nucleotide-excision repair (GO:0006289)?
Nucleotide-excision repair is a DNA repair process that removes a short oligonucleotide containing helix-distorting lesions such as UV photoproducts and bulky adducts, followed by DNA synthesis and ligation.
What genes are involved in nucleotide-excision repair?
Key genes include XPA, XPC, ERCC2 (XPD), ERCC3 (XPB), ERCC4 (XPF), ERCC5 (XPG), ERCC8 (CSA), ERCC6 (CSB), DDB1, DDB2, and RPA1.
What are the two main subpathways of NER?
Global genome NER (GG-NER) surveys the entire genome, while transcription-coupled NER (TC-NER) repairs lesions that block RNA polymerase II.
What diseases are caused by defective nucleotide-excision repair?
Defects cause xeroderma pigmentosum, Cockayne syndrome, trichothiodystrophy, and increased cancer predisposition.
How does NER recognize DNA damage?
GG-NER uses XPC-RAD23B and UV-DDB to detect helix distortions, while TC-NER relies on stalled RNA polymerase II and CSA/CSB.
What is the difference between NER and base excision repair?
NER removes bulky, helix-distorting lesions as an oligonucleotide, whereas base excision repair removes small, non-helix-distorting damaged bases.
How can CRISPR be used to study nucleotide-excision repair?
CRISPR knockout, knock-in, and overexpression models enable functional studies of NER genes, variant modeling, and screening for repair modifiers.
Why is transcription-coupled NER important?
TC-NER rapidly repairs transcription-blocking lesions, preventing transcription stress, genome instability, and cell death.
What experimental methods are used to measure NER activity?
Common methods include comet assay, immunofluorescence for repair foci, RNA-seq, proteomics, and live-cell imaging.
Is NER involved in cancer therapy resistance?
Yes, high NER activity can confer resistance to platinum-based drugs, making NER components potential biomarkers and targets.
Conclusion
GO:0006289 nucleotide-excision repair is a fundamental DNA repair pathway that protects genome integrity against UV radiation and chemical carcinogens. Its molecular mechanisms, key genes, and disease associations have been extensively characterized, providing a rich framework for biomedical research. Advances in CRISPR-based modeling and functional genomics continue to accelerate the discovery of NER regulators and their roles in cancer, neurodegeneration, and development. Understanding NER not only illuminates basic DNA repair biology but also informs therapeutic strategies for diseases linked to defective repair.
References
- 1. Nieto Moreno N et al.. 2023. Transcription-Coupled Nucleotide Excision Repair and the Transcriptional Response to UV-Induced DNA Damage.. Annu Rev Biochem 92:81-113 PMID: 37040775
- 2. Zhang X et al.. 2022. Nucleotide excision repair: a versatile and smart toolkit.. Acta Biochim Biophys Sin (Shanghai) 54(6):807-819 PMID: 35975604
- 3. Apostolou Z et al.. 2019. Nucleotide Excision Repair and Transcription-Associated Genome Instability.. Bioessays 41(4):e1800201 PMID: 30919497
- 4. Araújo SJ et al.. 2019. Nucleotide excision repair genes shaping embryonic development.. Open Biol 9(10):190166 PMID: 31662099
- 5. Krasikova Y et al.. 2021. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities.. Int J Mol Sci 22(12) PMID: 34207557
- 6. Li W et al.. 2022. Epigenetic Regulation of Nucleotide Excision Repair.. Front Cell Dev Biol 10:847051 PMID: 35465333
- 7. D'Souza A et al.. 2024. Protein-protein interactions in the core nucleotide excision repair pathway.. DNA Repair (Amst) 141:103728 PMID: 39029374
- 8. Spivak G. 2015. Nucleotide excision repair in humans.. DNA Repair (Amst) 36:13-18 PMID: 26388429
